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Summan The factors that determine progression of cervical intraepithelial neoplasia (CIN) to squamous cell carcinoma (SCC) are unknown. Cigarette smoking is an independent risk factor for cervical neoplasia. suggesting that polymorphism at detoxicating enzyme loci such as cvtochrome P450 CYP2D6 and glutathione S-transferase GSTM I mav determine susceptibility to these cancers. We have studied the frequencies of genotypes at these loci in women suffering low-grade CIN. high-grade CIN and SCC. A non-cancer control group uas pros ided by women with normal cervical histology suffering menorrhagia. Comparison of the frequency distributions of the CYP'D6 PM. HET and EM genotypes (G-*A transition at intron 3 exon 4 and base pair deletion in exon 5) revealed no significant differences between the menorrhagia and SCC groups. Frequency distributions in the menorrhagia group. however, were significantlv different (P <0.04) from those in the lou-and high-grade CIN groups. Thus. the proportion of EM was significantly larger (P <0.03) and of HET generally lower. We found that the frequency of GSTMI null in the menorrhagia and case groups was not significantly different. Interactive effects of enzyme genotypes with cigarette smoking were studied bv comparing the multinomial frequency distributions of CYP2D6 EM GSTMI null smoking over mutuallv exclusive categories. These showed no significant differences between the menorrhagia group and SCC or low-grade CIN groups. The frequency distribution in high-grade CIN. however. was significantlv different to that in the menorrhagia group and in both SCC and low-grade CIN groups. This study has identified, for the first time. an inherited characteristic in women with high-grade CIN who appear to be at reduced risk of SCC. Thus. women with CYP2D6 EM who smoke have increased susceptibility to high-grade CIN but are less likelv to progress to SCC. possibly because they effectively detoxify an unidentified chemical involved in mediating disease progression.
The natural history of squamous cell cancer of the cervix (SCC) is uncertain. Convention proposes a progression of cervical intraepithelial neoplasia (CIN) that culminates in invasive disease (McIndoe et al.. 1984; Anderson. 1991 (Winkelstein. 1990; Gram et al.. 1992; Burger et al., 1993). Further. DNA from cervical epithelial cells of smokers contains adducts of the type expected from reaction with polycyclic aromatic hydrocarbons and aromatic amines, both constituents of smoke. Women with abnormal cervical cytology demonstrate the highest proportions of adducts (Simons et al.. 1993) . Data showing that metastatic progression of primary cervical cancers may be accompanied by GC-*TA transversions in p53 also suggest a role for carcinogens such as benzpyrene and aflatoxin B (Crook et al., 1992) , although mutations in the hotspot regions of this gene appear to be infrequent in cervical carcinomas (Paquette et al.. 1993 : Busby-Earle et al.. 1994 (Gough et al.. 1990 : Wolf et al.. 1992 (Wolf et al.. 1992) .
The phase 2 glutathione S-transferases are also relevant. Thus. GSTM 1 isoforms catalyse the detoxication of genotoxic epoxides (e.g. benzpyrene). GSTM 1 genotypes anse from combinations of the GSTMI*O. GSTMI*A and GSTMI*B alleles. GSTMI*O is deleted and homozygotes (GSTM 1 null) express no protein (Seidegard et al.. 1988 : Pearson et al.. 1993 : Strange. 1993 (Seidegard et al.. 1988 : Zhong et al.. 1991 : Strange. 1993 . Support also comes from recent studies shoWing that the heterozygote GSTM1 A B genotype is protective in basal cell carcinoma of skin. suggesting that two expressed alleles con-fer better protection than GSTMI*O heterozygosity (Heagerty et al.. 1994 Identification of CYP2D6 and GSTMJ genotypes The two mutant CYP2D6 alleles (G-*A transition at intron 3 exon 4 and base pair deletion in exon 5) were identified in separate polymerase chain reaction (PCR) assays. Together these assays are about 90% predictive of phenotype (Gough et al.. 1990; Wolf et al.. 1992 ). The G-*A transition was identified using intron 3 exon 4 primers followed by BstNI digestion. Amplified DNA from homozygotes (PM genotype) was not digested. The base pair deletion in exon 5 was identified using primers to exon 5 intron 5 followed by HpaII digestion. Amplified DNA from homozygotes for the mutant allele (PM genotype) was digested (Gough et al., 1990; Wolf et al.. 1992 ).
The GSTM 1 null genotype was identified in leucocyte DNA using a modified amplification refractory mutation system (ARMS)-based PCR (Fryer et al., 1993; Heagerty et al.. 1994) . Amplification was carried out using primer sets to intron 6 exon 7 and exon 4,exon 5 of GSTM I and, as positive control. frglobin primers.
Statistical analysis r tests were used to examine for homogeneity between cases and controls. Since some genotype frequencies were small, the StatXact-Turbo statistical package was used to obtain exact P-values.
As three factors (CYP2D6 EM, GSTM 1 null, smoking) were studied, the influence on disease susceptibility of each (alone and in combination in pairs and triplets) was studied by comparing frequency distributions over the resulting mutually exclusive categories. Thus, in any patient group the GSTMI null subjects comprise individuals who are GSTM1 null only, GSTM 1 null/CYP2D6 EM only, GSTM 1 null/ smoking only and GSTMI null/CYP2D6 EM/smoking. The advantage of this approach is that it allows identification of those factors (alone and in combination) that contribute most to observed differences between cases and controls.
Results
Genotype frequencies in the patient groups were analysed in the order CYP2D6 alone, CYP2D6 EM with smoking, GSTM1 null and both genes in combination with smoking.
Frequency of CYP2D6 genotipes Frequency distributions of CYP2D6 genotypes in women with normal uterine histology or leiomyoma were not signficantly different. For example. frequencies of the CYP2D6 PM G-*A transition were 5.2% and 4.8% respectively. Data from the two groups were, therefore, combined (Table I ). The frequencies of the CYP2D6 genotypes (G-*A transition) in the menorrhagia group (Table I) were similar to those in Sheffield controls (Wolf et al., 1992) , and the frequencies of both the G-*A transition and exon 5 deletion in these subjects and the North Staffordshire controls were similar. Table I shows the frequencies of CYP2D6 genotypes (G-*A transition. the exon 5 deletion and these mutations together) in the CIN. SCC and menorrhagia groups. Frequenc) distributions of genotypes in the menorrhagia group and SCC were not different. but those in the menorrhagia group and high-grade CIN were significantly different for the G-*A transition alone and both mutations combined. Thus, the frequency of EM was significantly larger and of HET (heterozygotes for one of the mutations examined) significantly lower (Table I ). The frequency distributions of EM, HET and PM (both mutations) in the menorrhagia and low-grade CIN groups were also significantly different (Table  I) . Thus. the proportion of patients with EM was significantly larger in low-grade CIN. while that of HET (each mutation) approached significance ( Table I ). The frequencies of the wild-type allele. calculated from the data in Table I (Table II) .
Frequency of GST.VI genotypes
The frequencies of GSTM 1 null in women with normal uterine histology or leiomyoma (60% and 58% respectively) were not significantly different, and data from the two groups were, therefore. combined (Table III) . Although Table III shows the frequency of GSTM1 null in this menorrhagia group to be rather higher than previously reported for some. but not all. non-cancer controls (Seidegard et Frequenci of combinations of GSTMJ null, CYP2D6 and smoking The importance of the CYP2D6 EM (both mutations) and GSTM1 null in combination in smoking and non-smoking cases and menorrhagia subjects was studied by comparing multinomial frequency distributions in mutually exclusive categories (Table IV) .
Comparison of these frequency distnrbutions showed no significant differences between the menorrhagia group and SCC or low-grade CIN or between patients with SCC and those with low-grade CIN. The frequency distribution of genotypes in high-grade CIN, however, was significantly different to that in the menorrhagia subjects and in those with both SCC and low-grade CIN. (Table IV) .
In keeping with the data in Table III . the GSTM1 null genotype did not appear to be an important factor in determining susceptibility to cervical neoplasia. Thus, the frequencies of the genotype alone, in combination with smoking, in combination with CYP2D6 EM or in combination with both smoking and CYP2D6 EM in the menorrhagia or three case groups were not significantly increased. (Wolf et al., 1992) . The GSTMI null frequency in the menorrhagia group, however. was rather higher than expected. It is worth emphasising that, while allelic variation at these gene loci has attracted attention because it may influence susceptibility to various malignancies, the mechanism is unclear (Seidegard et al.. 1988; Strange. 1993) . Thus, while the role of GSTM1 enzymes in the detoxication of potential carcinogens such as epoxides appears critical, their putative role in DNA repair implies that GSTM 1 null may confer susceptibility to inflammatory damage. However, data showing an increased frequency of GSTM 1 null in prolactinoma, a generally benign tumour not associated with inflammatory cell infiltration or exogenous chemicals, do not support either of these hypotheses (Strange, 1993) . Prolactinomas appear to be sex hormone dependent. and while there is no obvious link between GSTM1 and detoxication of these hormones. androstene-3',1 7-dione is a relatively poor substrate for human mu enzymes. It is possible that GSTM1 null is associated with an increased risk of menorrhagia because of altered detoxication of steroids. Similarly, for CYP2D6 much interest has centred on susceptibility to cancer though the in vivo substrates are unknown and data showing that the PM genotype is associated with increased susceptibility to Parkinson's disease suggest the importance of endogenous neurotoxins (Smith et al.. 1992) .
We found no association of SCC with increased frequency of GSTMI null or CYP2D6 EM. either individually or in combination with smoking. Indeed, the frequency of nonsmoking,non-GSTM null non-CYP2D6 EM was significantly greater than in the menorrhagia and low-and highgrade CIN groups. Unexpectedly, the high-grade CIN group demonstrated differences from the menorrhagia and other case groups. Thus, the frequency of CYP2D6 EM was different from the menorrhagia group and multinomial frequency distributions were different from those in SCC and low-grade CIN and the combination of smoking, CYP2D6 EM was more common than in SCC or low-grade CIN. Differences in the frequency distribution of CYP2D6 genotypes in the lowgrade CIN and menorrhagia groups were also identified.
Our data indicate that susceptibility to SCC is not associated with GSTMI null or CYP2D6 EM. High-grade CIN, however, is associated with an increased frequency of smoking and CYP2D6 EM. While high-grade CIN is recognised as a precursor for invasive disease, its relationship with SCC is unclear. Thus, the incidence of high-grade CIN has increased, while that of SCC has fallen, a process that preceded national cervical screening (Anderson, 1991) . This indicates that not all lesions with the histopathological appearance of high-grade CIN are premalignant. Conversely, some SCCs may not be preceded by CIN (Anderson. 1991) . Our data suggests that women with CYP2D6 EM who smoke have increased susceptibility to CIN but are less likely to progress to SCC. The mechanism for this effect is unknown but is compatible with the view that detoxicating enzyme genotypes will increase or decrease disease risk depending on the particular causative substrates (Smith et al.. 1992; Wolf et al., 1992; Pemble et al., 1994 Cigarette smoke comprises a complex mixture of chemicals. including many known carcinogens. While the compounds involved in the development of CIN and SCC are currently unidentified, certain tobacco-specific N-nitrosamines are substrates for CYP2D6 and. therefore. candidates. Thus, exposure of a human lymphoblastoid line expressing a CYP2D6 cDNA to the procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-l-butanone results in a concentration-dependent decrease in cell survival. These data suggest that individuals with the CYP2D6 EM genotype who smoke may form activated, mutagenic metabolites of the procarcinogen that undergo methylation and pyridyloxobutylation reactions with DNA (Crespi et al.. 1991) . However. while 4-(methylnitrosamino)-1 -(3-pyridyl)-1 -butanone and its CYP2D6-catalysed activation may be involved in the pathogenesis of CIN. the carcinogen that is required for progression to SCC and is effectively detoxicated by CYP2D6 EM individuals is unknown.
We have described the first biochemical data identifying women with high-grade CIN who appear to be at reduced risk of progression to invasive disease. Recent studies showing the interactive effects of genotypes at loci encoding detoxifying enzymes such as CYPlAl and GSTM1 (Nakachi et al., 1993) suggest that the influence of CYP2D6 in mediating susceptibility to cervical neoplasia will also be modified by polymorphisms at other relevant loci.
